Dr Sue Snape
Dr Sue Snape joined Argenta in December 2007 from Sosei R&D Ltd. where she was responsible for the development of a number of compounds in the company’s portfolio. Sue is a Biochemist by training and holds a BSc (Hons) from the University of York. She obtained her PhD whilst working at the MRC Clinical Research Centre and Kings College Hospital and holds an MBA from the University of Cambridge.
Sue has over 16 years experience within drug development and has held a variety of management positions within program management, clinical development and biometrics at a number of pharmaceutical companies and Contract Research Organisations.
Argenta Discovery Limited is a company incorporated and registered in England with registered number 3671653 whose registered office and principal place of business is at 8/9 Spire Green Centre, Flex Meadow, Harlow, CM19 5TR, United Kingdom and whose VAT registration number is GB 848 2268 02.